ALBEMARLE CORP annual report, FY2022

Albemarle Corporation: FY2022 Form 10-K Summary

Business context and reporting period

Albemarle is a global specialty-chemicals producer serving energy storage, petroleum refining, consumer electronics, construction, automotive, pharmaceuticals and other markets. The filing covers the fiscal year ended December 31, 2022, with comparisons to 2021 and 2020. Reportable segments during 2022 were Lithium, Bromine and Catalysts. Effective January 1, 2023, the Company reorganized into Energy Storage, Specialties and Ketjen (Catalysts).

The Company served approximately 1,900 customers in approximately 70 countries, operated more than 25 production and research facilities, and had approximately 7,400 employees. Approximately 88% of sales were to foreign countries; China represented 33% of 2022 net sales.

Key financial metrics

Metric20222021Change
Net sales$7.320 billion$3.328 billion+120%
Gross profit$3.075 billion$998.0 million+208%
Gross margin42.0%30.0%+12.0 percentage points
Operating profit$2.470 billion$798.4 million+209%
Net income attributable to Albemarle$2.690 billion$123.7 million+2,075%
Diluted EPS$22.84$1.06+2,055%
Adjusted EBITDA$3.476 billion$871.0 million+299%
Cash flow from operations$1.908 billion$344.3 million+454%
Capital expenditures$1.262 billion$953.7 million+32%

Net income benefited substantially from lithium pricing, higher sales volumes, increased equity earnings from the Talison joint venture and unusual items affecting the prior-year comparison. The 2022 effective tax rate was 16.1%, compared with 22.0% in 2021, including a $91.8 million benefit from releasing an Australian valuation allowance and a $72.6 million foreign-derived intangible income benefit.

Segment performance

Segment2022 salesSales change2022 adjusted EBITDAEBITDA change
Lithium$5.009 billion+267%$3.103 billion+547%
Bromine$1.412 billion+25%$456.9 million+27%
Catalysts$899.6 million+18%$28.7 million-73%
  • Lithium: Sales increased primarily from approximately $3.2 billion of favorable pricing, greater exposure to index-referenced and variable-priced contracts, and $549.2 million of higher volume. Adjusted EBITDA also benefited from higher Talison earnings and productivity improvements, partially offset by Chilean commissions, freight, utilities, SG&A and growth spending.
  • Bromine: Pricing contributed approximately $260.6 million and volume contributed $49.8 million. Higher freight, utilities and raw-material costs limited profitability growth.
  • Catalysts: Sales increased on higher volume and pricing, but adjusted EBITDA declined because of European natural-gas costs, raw-material and freight inflation, and a fourth-quarter U.S. winter freeze. Results included a $10 million contingent business-interruption insurance gain and $7 million of Netherlands government grants.

Cash flow, liquidity and debt

  • Cash and cash equivalents increased to $1.499 billion at December 31, 2022, from $439.3 million. Approximately $1.3 billion was held by foreign subsidiaries.
  • Operating cash flow of $1.908 billion was partly offset by $1.262 billion of capital expenditures, $705.0 million of debt and credit-agreement repayments, $391.7 million of net commercial-paper repayment, $332.5 million paid to settle the Huntsman arbitration matter, and $184.4 million of shareholder dividends.
  • Total long-term debt was $3.217 billion, including $3.215 billion excluding the current portion, compared with $2.394 billion at December 31, 2021. The increase followed the issuance of $1.7 billion of senior notes in May 2022.
  • The May 2022 notes comprise $650 million due 2027 at 4.65%, $600 million due 2032 at 5.05%, and $450 million due 2052 at 5.65%. No commercial paper or borrowings under the $1.5 billion revolving credit facility were outstanding at year-end.
  • The Company reported compliance with its debt covenants. The revolving facility requires a consolidated net funded debt-to-consolidated EBITDA ratio of no more than 3.50:1, subject to specified acquisition adjustments.
  • Debt maturities are $2.1 million in 2023, none in 2024, $401.3 million in 2025, $650.0 million in 2027 and $2.192 billion thereafter. Available liquidity included $1.5 billion under the commercial-paper program and revolving credit facility, subject to conditions and covenants.

Material changes versus the prior comparable period

  • Record results were driven mainly by tight lithium market conditions and higher realized prices, particularly for battery- and technology-grade lithium carbonate and hydroxide.
  • Wodgina spodumene production resumed in the second quarter of 2022 after being idled since 2019.
  • Albemarle acquired Qinzhou for approximately $200 million in cash. The facility has designed conversion capacity of up to 25,000 metric tonnes of LCE annually; it did not contribute material sales or net income in the post-acquisition period.
  • The Company issued $1.7 billion of senior notes, redeemed the $425 million of 4.15% notes due 2024, repaid commercial paper and terminated a $1.2 billion credit facility with a $250 million repayment.
  • Capital spending rose to $1.262 billion, led by lithium growth projects. The Company also completed or advanced capacity projects in Chile and Australia and continued construction of the Meishan, China conversion plant.
  • Unlike 2021, 2022 did not include the $428.4 million pretax gain from the FCS divestiture or the $657.4 million pretax Huntsman arbitration accrual. The final $332.5 million Huntsman settlement payment was made in May 2022.
  • Interest expense increased to $123.0 million, including a $19.2 million loss on early debt extinguishment and a $17.5 million correction of prior-period capitalized-interest errors.
  • Management identified and remediated prior-year deficiencies in controls over certain SEC mining disclosures. Management and the independent auditor concluded that internal control over financial reporting was effective as of December 31, 2022, excluding the recently acquired Qinzhou business from the assessment.

Guidance, outlook and unusual items

  • Management expected 2023 Energy Storage results to increase year over year through higher pricing and volume, supported by new capacity in Chile, Australia and China, the Qinzhou acquisition and continued tolling arrangements.
  • Management expected Specialties sales and profitability to increase, supported by demand, pricing, growth projects and the MercLok product launch, while noting continued exposure to chlorine, freight and raw-material availability.
  • Management expected Ketjen results to increase despite inflationary freight and input costs, including European natural-gas volatility related to the Russia-Ukraine conflict. Higher refining-market pricing and volume were expected to offset much of the cost pressure.
  • 2023 capital expenditures were expected to be $1.7 billion to $1.9 billion, primarily for Energy Storage capacity and growth projects in Australia, Chile, China and Nevada.
  • Ketjen was pursuing contingent business-interruption insurance claims that could provide up to an additional $47 million in 2023 if successful; the timing and outcome were uncertain.
  • Management stated that lithium market indices had increased 70% to 200% since the beginning of 2022, but warned that a material decline could negatively affect revenue and profitability because more contracts are now index-referenced or variable-priced.
  • Key contingencies include unresolved DOJ, SEC and Dutch Public Prosecutor investigations concerning potential improper payments by third-party sales representatives in the Catalysts business. Albemarle could not predict the duration, outcome or costs, although it did not expect a material effect on financial condition or liquidity.
  • Environmental remediation liabilities totaled $38.2 million, with management estimating a reasonable possibility of approximately $9 million of additional costs before tax. Legal matters, product liability, regulatory changes, cybersecurity, foreign exchange, climate, water availability and project execution remain significant risks.

Most important facts for investors to verify

  1. Whether lithium prices and index-linked contract exposure remain strong enough to support the 2023 Energy Storage outlook.
  2. The timing, cost and ramp-up of La Negra, Kemerton, Qinzhou, Meishan, Silver Peak and planned Kings Mountain projects, including the expected $1.7 billion to $1.9 billion of 2023 capital spending.
  3. Debt-service capacity and covenant compliance as capital expenditures, working capital and interest costs increase.
  4. The effect of lithium-price declines, alternative battery technologies, supply additions and competition on margins and resource economics.
  5. The status and potential financial, regulatory and reputational consequences of the FCPA-related investigations.
  6. Exposure to China, which represented 33% of 2022 sales, and to geopolitical, trade, currency, energy and supply-chain disruptions.
  7. The assumptions supporting mineral reserves and resources, especially the absence of declared reserves at Wodgina and the permit, quota and concession limitations affecting Chile and Jordan.
  8. The sensitivity of Catalysts profitability to natural-gas, freight and raw-material costs and to lumpy refinery-catalyst replacement cycles.
  9. The treatment and timing of unusual items, including the Qinzhou purchase-price allocation, Kemerton cost overruns, pension gains, tax benefits and insurance recoveries.